Dr. Ollila is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
593 Eddy St
Providence, RI 02903- Is this information wrong?
Education & Training
Brown UniversityResidency, Internal Medicine, 2012 - 2015
Drexel University College of MedicineClass of 2012
Certifications & Licensure
RI State Medical License 2012 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.Narendranath Epperla, Lei Feng, Nirav N Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M Stephens, Catherine J Lee, Thomas Ollila, Geoffrey Shouse, Alexey V Danilov, Ke...> ;Journal of Hematology & Oncology. 2023 Nov 9
- Drug-induced hypersensitivity syndrome and eosinophils in skin biopsy in a patient with pancytopenia.Benjamin Gallo Marin, Thomas A Ollila, Allison Robbins, Blake E Brooks, Elnaz F Firoz, Cathy M Massoud> ;American Journal of Hematology. 2023 Apr 1
- 9 citationsPeri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B Cohen, Tamara K Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sa...> ;Blood Advances. 2023 Jun 27
- Join now to see all
Abstracts/Posters
- Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive LymphomasThomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Exposure to Ibritumomab Tiuxetan and Incidence of Treatment-Related Myeloid Neoplasms Among Older Patients with B-Cell Lymphoma: A Population-Based StudyThomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone LymphomaThomas A Ollila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Lifespan Study Looks at Antibody Levels in Some Fully Vaccinated Cancer PatientsAugust 17th, 2021
Hospital Affiliations
Rhode Island HospitalProvidence, Rhode Island
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
